← Back to Search

Radiation

Radiation Therapy for Follicular Lymphoma

N/A
Recruiting
Led By May Tsao, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month and 3 month
Awards & highlights

Study Summary

This trial is looking at what the best dose of radiation is to treat low grade follicular lymphoma while minimizing side effects.

Who is the study for?
This trial is for adults over 18 with low-grade (grade 1-2) follicular lymphoma that hasn't been treated with radiation before. It's for those who need radiation for local disease control, have non-bulky targets under 7cm, and can consent to treatment. Pregnant individuals or those on systemic therapy for lymphoma within the last 3 months are excluded.Check my eligibility
What is being tested?
The study is testing a specific intermediate dose of radiation (12 Gy in 6 daily fractions) to see if it effectively treats follicular lymphoma while reducing both immediate and long-term side effects. The goal is an excellent response rate with minimal toxicity.See study design
What are the potential side effects?
Potential side effects may include skin reactions at the treatment site, fatigue, mild discomfort or pain, and possible late-onset effects related to irradiated tissues which will be closely monitored.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month and 3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month and 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Complete response within the radiated volume at 1month post radiation
Secondary outcome measures
Overall survival, progression-free survival and toxicity

Trial Design

1Treatment groups
Experimental Treatment
Group I: 12 Gy in 6 daily fractionsExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,281 Total Patients Enrolled
May Tsao, MDPrincipal InvestigatorSunnybrook Health Sciences Centre

Media Library

12 Gy in 6 daily fractions (Radiation) Clinical Trial Eligibility Overview. Trial Name: NCT05284825 — N/A
Follicular Lymphoma Research Study Groups: 12 Gy in 6 daily fractions
Follicular Lymphoma Clinical Trial 2023: 12 Gy in 6 daily fractions Highlights & Side Effects. Trial Name: NCT05284825 — N/A
12 Gy in 6 daily fractions (Radiation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05284825 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment actively seeking participants?

"Yes, clinicaltrials.gov affirms that this medical trial is currently seeking participants. The initial post was on February 28th 2022 and the most recent update took place on March 10th 2022."

Answered by AI

What is the number of participants in this investigation?

"Affirmative. Clinicaltrials.gov records that this research is actively seeking participants, with the initial post being made on February 28th 2022 and revised on March 10th of the same year. 27 subjects need to be enrolled from one site for the study's completion."

Answered by AI

Does the FDA sanction 12 Gy split into six daily fractions?

"A score of 2 was assigned to 12 Gy in 6 daily fractions due to the lack of evidence supporting efficacy, but some data indicating safety."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
2022. "A Phase II Trial of Intermediate Radiation Dose For Lymphoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05284825.
~6 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top